Intellectual Property India Publishes Patent Application for 'Anti-Cd122 Antibodies And Uses Thereof' Filed by Forte Subsidiary, Inc.

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517031136 A) filed by Forte Subsidiary, Inc., Dallas, U.S.A., on March 29, for 'anti-cd122 antibodies and uses thereof.'

Inventor(s) include Wagner, Paul A.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "Provided herein, in certain aspects, are anti-CD122 antibodies and pharmaceutical compositions which comprise anti-CD122 antibodies. In some embodiments, the anti-CD122 antibodies and the pharmaceutical compositions comprising anti-CD122 antibodies can be used for targeting CD122-expressing tissues and cells."

The patent application was inter...